For more information on a session, and session report please click on the session title (blue link).
|
Clyde |
Lomond |
Hall 1 |
Forth |
Alsh |
Boisedale |
Carron |
8.30 |
|
BCIS
Controversial issuesin angio-plastyand abstracts (1-2) |

BSH/BSCMR
Should CMR be used routinely in heart failure? |
BHF
Adult CV disease from developm-ental biology |
|
|
|
10.00 |
| Exhibition break |
Moderated Posters in exhibition
( 3 - 1 4 ) |
|
| 11.30 |
BAS/BSCR/
BCIS
Endothelial dysfunction and thrombosis following stenting: scientific and clinical issues |
|
BSH/HRUK
Atrial fibrillation in heart failure |
BSE
New techniques in the echo lab |
BACR
Promoting physical activity in the
sedentary cardiac patient |
|
|
| 13.00 |
|
13.15 |
Exhibition break |
|
|
|
|
|
|
14.30 |
|
BCS/ACC
Avoiding complications
with cardiovascular
drugs |
BSE
Multimodality
monitoring of
valve disease |
|
|
|
|
16.00 |
Exhibition break |
17.00 |
|
|
|
|
|
|
|
| 18.00 |
|
|
|
Sponsored symposium
Daichii-Sankyo/Lilly
Optimal antiplatelet
treatment of ACS patients
undergoing PCI |
|
Sponsored symposium
sanofi-aventis
Cardio-vascular disease,
abdominal obesity and the
endocann-abinoid system |
|
|
|